Reversal of promoter DNA hypermethylation and associated gene silencing is an attractive malignancy therapy approach. and Taylor, 1980), have recently emerged as potent treatments for the pre-leukemic hematological disease, myelodysplastic syndrome (MDS), and for founded leukemias (Blum et al., 2007; Cashen et al., 2009; Issa et al., 2004), leading to FDA authorization for individuals with… Continue reading Reversal of promoter DNA hypermethylation and associated gene silencing is an